Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Ticagrelor Oral Tablet - Pre-Treatment and Post-Treatment
DRUG
2 trials
Sponsors
SFJ Pharmaceuticals, Inc.
Conditions
Healthy
Phase 1
Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers
Completed
NCT03492385
SFJ Pharmaceuticals, Inc.
Healthy
Start: 2018-04-03
End: 2018-09-18
Updated: 2024-11-04
Phase 2
Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects
Completed
NCT03928353
SFJ Pharmaceuticals, Inc.
Healthy
Start: 2019-04-16
End: 2019-10-09
Updated: 2024-05-01
Related Papers
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
New England Journal of Medicine
2019-03-17
131 citations